Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KAITLIN M JASMON

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant

NPI
1760805949
CMS profile
11250133
Location
INDIANAPOLIS, IN

General Payments · PY2022–2024

$2,186.13

  • Reported across 63 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,405.95

39 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,405.95 39

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2022 $291.38 7
PY2023 $488.80 17
PY2024 $1,405.95 39

Payment records · PY2024 (39)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Actelion Pharmaceuticals US, Inc. $121.18 09/10/2024 Food and Beverage Undisputed 01/23/2026 1078887097 CMS
Amgen Inc. $22.86 12/10/2024 Food and Beverage Undisputed 01/23/2026 1117286835 CMS
AstraZeneca Pharmaceuticals LP $23.33 04/01/2024 Food and Beverage Undisputed 01/23/2026 1105498520 CMS
AstraZeneca Pharmaceuticals LP $14.21 09/17/2024 Food and Beverage Undisputed 01/23/2026 1104527816 CMS
AstraZeneca Pharmaceuticals LP $15.67 11/08/2024 Food and Beverage Undisputed 01/23/2026 1105548263 CMS
AstraZeneca Pharmaceuticals LP $15.83 11/19/2024 Food and Beverage Undisputed 01/23/2026 1104755940 CMS
GENZYME CORPORATION $38.84 07/22/2024 Food and Beverage Undisputed 01/23/2026 1139598329 CMS
GENZYME CORPORATION $20.28 10/07/2024 Food and Beverage Undisputed 01/23/2026 1139598521 CMS
GENZYME CORPORATION $124.26 10/29/2024 Food and Beverage Undisputed 01/23/2026 1139598513 CMS
GENZYME CORPORATION $27.60 11/11/2024 Food and Beverage Undisputed 01/23/2026 1139598511 CMS
GENZYME CORPORATION $121.18 11/20/2024 Food and Beverage Undisputed 01/23/2026 1139598539 CMS
GlaxoSmithKline, LLC. $121.18 09/25/2024 Food and Beverage Undisputed 01/23/2026 1116673120 CMS
GlaxoSmithKline, LLC. $13.61 10/04/2024 Food and Beverage Undisputed 01/23/2026 1116422443 CMS
Grifols USA, LLC $23.85 06/12/2024 Food and Beverage Undisputed 01/23/2026 1124716440 CMS
Grifols USA, LLC $6.69 08/28/2024 Food and Beverage Undisputed 01/23/2026 1124730245 CMS
Grifols USA, LLC $13.41 09/23/2024 Food and Beverage Undisputed 01/23/2026 1124730243 CMS
Grifols USA, LLC $11.10 10/08/2024 Food and Beverage Undisputed 01/23/2026 1124716442 CMS
Grifols USA, LLC $108.37 10/22/2024 Food and Beverage Undisputed 01/23/2026 1124716434 CMS
Grifols USA, LLC $14.36 11/12/2024 Food and Beverage Undisputed 01/23/2026 1124716430 CMS
Grifols USA, LLC $21.38 12/04/2024 Food and Beverage Undisputed 01/23/2026 1124716432 CMS
Grifols USA, LLC $6.23 12/12/2024 Food and Beverage Undisputed 01/23/2026 1124716436 CMS
Grifols USA, LLC $13.33 12/16/2024 Food and Beverage Undisputed 01/23/2026 1124716438 CMS
INOGEN, INC. $14.76 08/27/2024 Food and Beverage Undisputed 01/23/2026 1144989955 CMS
Mylan Specialty L.P. $13.39 04/17/2024 Food and Beverage Undisputed 01/23/2026 1147348687 CMS
Mylan Specialty L.P. $13.89 07/17/2024 Food and Beverage Undisputed 01/23/2026 1147290996 CMS
Mylan Specialty L.P. $13.27 08/21/2024 Food and Beverage Undisputed 01/23/2026 1147300855 CMS
Mylan Specialty L.P. $13.39 10/23/2024 Food and Beverage Undisputed 01/23/2026 1147333841 CMS
Philips North America LLC $19.81 10/09/2024 Food and Beverage Undisputed 01/23/2026 1146879846 CMS
Pulmonx Corporation $14.44 06/13/2024 Food and Beverage Undisputed 01/23/2026 1087853238 CMS
Regeneron Healthcare Solutions, Inc. $22.82 09/03/2024 Food and Beverage Undisputed 01/23/2026 1114321026 CMS
Regeneron Healthcare Solutions, Inc. $25.91 10/29/2024 Food and Beverage Undisputed 01/23/2026 1114321028 CMS
Regeneron Healthcare Solutions, Inc. $17.86 11/26/2024 Food and Beverage Undisputed 01/23/2026 1114321030 CMS
Regeneron Healthcare Solutions, Inc. $120.83 12/20/2024 Food and Beverage Undisputed 01/23/2026 1114321032 CMS
Takeda Pharmaceuticals U.S.A., Inc. $21.76 06/03/2024 Food and Beverage Undisputed 01/23/2026 1137768957 CMS
Takeda Pharmaceuticals U.S.A., Inc. $16.58 07/30/2024 Food and Beverage Undisputed 01/23/2026 1137768959 CMS
Takeda Pharmaceuticals U.S.A., Inc. $105.21 08/14/2024 Food and Beverage Undisputed 01/23/2026 1137768961 CMS
Takeda Pharmaceuticals U.S.A., Inc. $26.07 08/27/2024 Food and Beverage Undisputed 01/23/2026 1137768963 CMS
Takeda Pharmaceuticals U.S.A., Inc. $18.26 10/08/2024 Food and Beverage Undisputed 01/23/2026 1137768965 CMS
Vifor Pharma, Inc. $28.95 09/06/2024 Food and Beverage Undisputed 01/23/2026 1124065632 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.